Resultados globales: 26 registros encontrados en 0.02 segundos.
Artículos, Encontrados 18 registros
Documentos de investigación, Encontrados 8 registros
Artículos Encontrados 18 registros  1 - 10siguiente  ir al registro:
1.
14 p, 558.9 KB The Banff 2019 Kidney Meeting Report (I) : Updates on and clarification of criteria for T cell- and antibody-mediated rejection / Loupy, Alexandre (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Haas, Mark (Cedars-Sinai Medical Center) ; Roufosse, Candice (Imperial College London and North West London Pathology) ; Naesens, Maarten (University Hospitals Leuven) ; Adam, Benjamin (University of Alberta) ; Afrouzian, Marjan (University of Texas Medical Branch) ; Akalin, Enver (Montefiore Medical Center) ; Alachkar, Nada (Johns Hopkins University School of Medicine) ; Bagnasco, Serena (Johns Hopkins University School of Medicine) ; Becker, Jan U. (University Hospital of Cologne) ; Cornell, Lynn D. (Mayo Clinic) ; Clahsen-van Groningen, Marian C. (Erasmus MC) ; Demetris, Anthony J. (University of Pittsburgh. University of Pittsburgh. The Thomas E Starzl Transplantation Institute) ; Dragun, Duska (Charite Universitätsmedizin. Berlin Institute of Health) ; Duong van Huyen, Jean-Paul (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Farris, Alton B. (Emory University) ; Fogo, Agnes B. (Vanderbilt University) ; Gibson, Ian W. (University of Manitoba) ; Glotz, Denis (INSERM U 1160. Université Paris VII. Hopital Saint Louis) ; Gueguen, Juliette (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Kikic, Zeljko (Medical University of Vienna) ; Kozakowski, Nicolas (Medical University of Vienna) ; Kraus, Edward (Johns Hopkins University School of Medicine) ; Lefaucheur, Carmen (INSERM U 1160. Université Paris VII. Hopital Saint Louis) ; Liapis, Helen (Washington University School of Medicine) ; Mannon, Roslyn B. (University of Alabama School of Medicine) ; Montgomery, Robert A. (NYU Langone Transplant Institute) ; Nankivell, Brian J. (Westmead Hospital) ; Nickeleit, Volker (The University of North Carolina) ; Nickerson, Peter (University of Manitoba) ; Rabant, Marion (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Racusen, Lorraine (Johns Hopkins University School of Medicine) ; Randhawa, Parmjeet (University of Pittsburgh. University of Pittsburgh. The Thomas E Starzl Transplantation Institute) ; Robin, Blaise (Assistance Publique - Hopitaux de Paris. Paris and Necker Hospital. Paris Translational Research Centre for Organ Transplantation. University of Paris. INSERM U970. Université de Paris) ; Rosales, Ivy A. (Harvard Medical School. Massachusetts General Hospital) ; Sapir-Pichhadze, Ruth (McGill University) ; Schinstock, Carrie A. (Mayo Clinic) ; Seron, Daniel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Singh, Harsharan K. (The University of North Carolina) ; Smith, Rex N. (Harvard Medical School. Massachusetts General Hospital) ; Stegall, Mark D. (Mayo Clinic) ; Zeevi, Adriana (University of Pittsburgh. University of Pittsburgh. The Thomas E Starzl Transplantation Institute) ; Solez, Kim (University of Alberta) ; Colvin, Robert B. (Harvard Medical School. Massachusetts General Hospital) ; Mengel, Michael (University of Alberta) ; Universitat Autònoma de Barcelona
The XV. Banff conference for allograft pathology was held in conjunction with the annual meeting of the American Society for Histocompatibility and Immunogenetics in Pittsburgh, PA (USA) and focused on refining recent updates to the classification, advances from the Banff working groups, and standardization of molecular diagnostics. [...]
2020 - 10.1111/ajt.15898
American Journal of Transplantation, Vol. 20 (may 2020) , p. 2318-2331  
2.
11 p, 909.4 KB Molecular profile of urine extracellular vesicles from normo-functional kidneys reveal minimal differences between living and deceased donors / Lozano-Ramos, S. Inés (Universitat Autónoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Bancu, Ioana (Institut Germans Trias i Pujol) ; Carreras-Planella, Laura (Universitat Autónoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Monguió-Tortajada, Marta (Universitat Autónoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Cañas, Laura (Universitat Autónoma de Barcelona. Departament de Medicina) ; Juega, Javier (Universitat Autónoma de Barcelona. Departament de Medicina) ; Bonet, Josep (Institut Germans Trias i Pujol) ; Armengol, M. Pilar (Institut Germans Trias i Pujol) ; Lauzurica, Ricardo (Institut Germans Trias i Pujol) ; Borràs, Francesc E. (Institut Germans Trias i Pujol)
Kidney transplantation (KTx) is the best therapeutic approach for chronic kidney diseases leading to irreversible kidney failure. Considering the origin of the graft, several studies have reported differences between living (LD) and deceased donors (DD) in graft and patient survival. [...]
2018 - 10.1186/s12882-018-0985-3
BMC Nephrology, Vol. 19 (july 2018)  
3.
12 p, 548.1 KB Mosaicism in Fanconi anemia : concise review and evaluation of published cases with focus on clinical course of blood count normalization / Nicoletti, Eileen (Rocket Pharmaceuticals, Inc., New York) ; Rao, Gayatri (Rocket Pharmaceuticals, Inc., New York, NY USA) ; Bueren, Juan A. (Instituto de Investigaciones Sanitarias Fundación Jiménez Díaz) ; Río, Paula (Instituto de Investigaciones Sanitarias Fundación Jiménez Díaz) ; Navarro, Susana (Instituto de Investigaciones Sanitarias Fundación Jiménez Díaz) ; Surrallés, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Choi, Grace (Rocket Pharmaceuticals, Inc., New York) ; Schwartz, Jonathan D. (Rocket Pharmaceuticals, Inc., New York) ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia
Fanconi anemia (FA) is a DNA repair disorder resulting from mutations in genes encoding for FA DNA repair complex components and is characterized by variable congenital abnormalities, bone marrow failure (BMF), and high incidences of malignancies. [...]
2020 - 10.1007/s00277-020-03954-2
Annals of Hematology, Vol. 99 (february 2020) , p. 913-924  
4.
12 p, 571.6 KB Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus / Torres, Armando (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Hernández, Domingo (Hospital Regional Universitario de Málaga, Universidad de Málaga, IBIMA, Málaga, Spain) ; Moreso, Francesc (Universitat Autònoma de Barcelona. Departament de Medicina) ; Serón, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Burgos, María Dolores (Hospital Regional Universitario de Málaga, Universidad de Málaga, IBIMA, Málaga, Spain) ; Pallardó, Luis M. (Hospital Universitario Dr Peset, Valencia, Spain) ; Kanter, Julia (Hospital Universitario Dr Peset, Valencia, Spain) ; Díaz Corte, Carmen (Hospital Universitario Central de Asturias, Oviedo, Spain) ; Rodríguez, Minerva (Hospital Universitario Central de Asturias, Oviedo, Spain) ; Díaz Gómez, Joan Manuel (Institut d'Investigació Biomèdica Sant Pau) ; Silva, Irene (Institut d'Investigació Biomèdica Sant Pau) ; Valdes, Francisco (Complexo Hospitalario Universitario Juan Canalejo, A Coruña, Spain) ; Fernández-Rivera, Constantino (Complexo Hospitalario Universitario Juan Canalejo, A Coruña, Spain) ; Osuna, Antonio (Hospital Universitario Virgen de las Nieves, Granada, Spain) ; Gracia Guindo, María C. (Hospital Universitario Virgen de las Nieves, Granada, Spain) ; Gómez Alamillo, Carlos (Hospital Universitario Marqués de Valdecilla, Santander, Spain) ; Ruiz, Juan C. (Hospital Universitario Marqués de Valdecilla, Santander, Spain) ; Marrero Miranda, Domingo (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Pérez-Tamajón, Lourdes (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Rodríguez, Aurelio (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; González-Rinne, Ana (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Alvarez, Alejandra (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Perez-Carreño, Estefanía (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; de la Vega Prieto, María José (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Henriquez, Fernando (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Spain) ; Gallego Samper, Roberto (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Spain) ; Salido, Eduardo (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Porrini, Esteban (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Universitat Autònoma de Barcelona
Despite the high incidence of posttransplant diabetes mellitus (PTDM) among high-risk recipients, no studies have investigated its prevention by immunosuppression optimization. We conducted an open-label, multicenter, randomized trial testing whether a tacrolimus-based immunosuppression and rapid steroid withdrawal (SW) within 1 week (Tac-SW) or cyclosporine A (CsA) with steroid minimization (SM) (CsA-SM), decreased the incidence of PTDM compared with tacrolimus with SM (Tac-SM). [...]
2018 - 10.1016/j.ekir.2018.07.009
Kidney International Reports, Vol. 3 (july 2018) , p. 1304-1315  
5.
8 p, 501.2 KB Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/ Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation / Sureda, Anna (Institut d'Investigació Biomèdica Sant Pau) ; Canals, Carme (European Society for Blood and Marrow Transplantation (Barcelona)) ; Arranz, Reyes (Hospital de la Princesa (Madrid)) ; Caballero, Dolores (Hospital Clínico Universitario (Salamanca)) ; Ribera, Josep Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Brune, Mats (Sahlgrenska University Hospital. Hematology Section) ; Passweg, Jacob (Hopitaux Universitaires de Geneve. Departement Medecine Interne) ; Martino, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Valcárcel, David (Institut d'Investigació Biomèdica Sant Pau) ; Besalduch, Joan (Hospital Son Dureta (Palma de Mallorca)) ; Duarte, Rafael (Institut Català d'Oncologia) ; León, Angel (Hospital de Jerez de la Frontera) ; Pascual, Maria Jesús (Hospital Carlos Haya (Málaga)) ; García-Noblejas, Ana (Hospital de la Princesa (Madrid)) ; López Corral, Lucia (Hospital Clínico Universitario (Salamanca)) ; Xicoy, Bianca (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sierra Gil, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Schmitz, Norbert (Asklepios Klinik St. Georg. Hematology/Oncology Department) ; Universitat Autònoma de Barcelona
Background: Although Hodgkin's lymphoma is a highly curable disease with modern chemotherapy protocols, some patients are primary refractory or relapse after first-line chemotherapy or even after high-dose therapy and autologous stem cell transplantation. [...]
2012 - 10.3324/haematol.2011.045757
Haematologica, Vol. 97, Núm. 2 (january 2012) , p. 310-317  
6.
15 p, 2.0 MB Monitoring t-cell responses in translational studies: optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-specific responses / Brinke, Anja ten (Sanquin Research (Amsterdam)) ; Marek-Trzonkowska,Natalia (Medical University of Gdansk. Department of Family Medicine) ; Mansilla López, María José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Turksma, Annelies W. (Sanquin Research (Amsterdam)) ; Piekarska, Karolina (Medical University of Gdansk. Department of Family Medicine) ; Iwaszkiewicz-Grzes, Dorota (Medical University of Gdansk. Department of Clinical Immunology and Transplantology) ; Passerini, Laura (IRCCS San Raffaele Scientific Institute) ; Locafaro, Grazia (IRCCS San Raffaele Scientific Institute) ; Puñet Ortiz, Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; van Ham, S. Marieke (Sanquin Research (Amsterdam)) ; Hernandez Fuentes, Maria P. (MRC Centre for Transplantation, King's College London) ; Martínez Cáceres, Eva M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gregori, Silvia (IRCCS San Raffaele Scientific Institute) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
Adoptive therapy with regulatory T cells or tolerance-inducing antigen (Ag)- presenting cells is innovative and promising therapeutic approach to control undesired and harmful activation of the immune system, as observed in autoimmune diseases, solid organ and bone marrow transplantation. [...]
2017
Frontiers in immunology, Vol. 8 (december 2017) , p. 1-15  
7.
15 p, 1.1 MB The Banff 2017 Kidney Meeting Report : Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials / Haas, M. (Cedars-Sinai Medical Center) ; Loupy, A. (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ; Lefaucheur, C. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Roufosse, C. (Imperial College London and North West London Pathology) ; Glotz, D. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Serón Micas, Daniel (Hospital Universitari Vall d'Hebron) ; Nankivell, B. J. (Westmead Hospital) ; Halloran, P. F. (University of Alberta) ; Colvin, R. B. (Harvard Medical School. Massachusetts General Hospital) ; Akalin, Enver (Montefiore Medical Center) ; Alachkar, N. (Johns Hopkins University School of Medicine) ; Bagnasco, S. (Johns Hopkins University School of Medicine) ; Bouatou, Y. (Geneva University Hospitals) ; Becker, J. U. (University Hospital of Cologne) ; Cornell, L. D. (Mayo Clinic) ; van Huyen, J. P. Duong (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ; Gibson, I. W. (University of Manitoba) ; Kraus, Edward S. (Johns Hopkins University) ; Mannon, R. B. (University of Alabama School of Medicine) ; Naesens, M. (University Hospitals Leuven. University of Leuven & Department of Nephrology) ; Nickeleit, V. (The University of North Carolina School of Medicine) ; Nickerson, P. (University of Manitoba) ; Segev, D. L. (Johns Hopkins Medical Institutions) ; Singh, H. K. (The University of North Carolina School of Medicine) ; Stegall, M. (Mayo Clinic) ; Randhawa, P. (University of Pittsburgh) ; Racusen, L. (Johns Hopkins University School of Medicine) ; Solez, K. (University of Alberta) ; Mengel, M. (University of Alberta) ; Universitat Autònoma de Barcelona
The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications of inflammation in areas of interstitial fibrosis and tubular atrophy (i-) and its relationship to T cell-mediated rejection (), and the continued evolution of molecular diagnostics, particularly in the diagnosis of antibody-mediated rejection (). [...]
2018 - 10.1111/ajt.14625
American Journal of Transplantation, Vol. 18, Issue 2 (February 2018) , p. 293-307  
8.
16 p, 3.0 MB The European Renal Association - European Dialysis and Transplant Association Registry Annual Report 2014 : a summary / Pippias, Maria (ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; Kramer, Anneke (ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; Noordzij, Marlies (ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; Afentakis, Nikolaos (Hellenic Renal Registry, Board of Registry, Coordination and Control of RRT, General Hospital of Athens 'G. Gennimatas', Athens, Greece) ; Alonso de la Torre, Ramón (Public Health Directorate, Asturias, Spain) ; Ambühl, Patrice M. (Swiss Dialysis Registry, Renal Division, Stadtspital Waid, Zurich, Switzerland) ; Aparicio Madre, Manuel I. (Registro Madrileño de Enfermos Renales (REMER), Oficina Regional de Coordinación de Trasplantes, Madrid, Spain) ; Arribas Monzón, Felipe (Aragon Renal Registry, Coordinación de Trasplantes de Aragón, Zaragoza, Spain) ; Åsberg, Anders (Norwegian Renal Registry, Department of Transplant Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway) ; Bonthuis, Marjolein (ESPN/ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; Bouzas Caamaño, Encarnación (Regional Transplant Coordination Office, Galicia, Spain) ; Bubic, Ivan (Department of Internal Medicine, Clinical Hospital Centre Rijeka, School of Medicine University of Rijeka, Rijeka, Croatia) ; Caskey, Fergus J. (UK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK) ; Castro de la Nuez, Pablo (Information System of Regional Transplant Coordination in Andalucia (SICATA), Andalucia, Spain) ; Cernevskis, Harijs (Department of Internal Medicine, Riga Stradins University, Riga, Latvia) ; de los Ángeles Garcia Bazaga, Maria (Dirección General de Salud Pública, Servicio Extremeño de Salud, Consejería de Sanidad y Políticas Sociales, Junta de Extremadura, Cáceres, Spain) ; des Grottes, Jean-Marin (CHU Tivoli, La Louvière, Belgium) ; Fernández González, Raquel (Registro de Enfermos Renales de Castilla y León, Coordinación de Trasplantes, Castilla y León, Spain) ; Ferrer-Alamar, Manuel (Técnico Registro de Enfermos Renales Comunitat Valenciana, Servicio de Estudios Epidemiológicos y Registros Sanitarios, Subdirección General Epidemiología, Dirección General Salut Pública, Consellería Sanitat, Valencian Region, Spain) ; Finne, Patrik (Finnish Registry for Kidney Diseases, Helsinki, Finland) ; Garneata, Liliana (Department of Internal Medicine and Nephrology 'Dr Carol Davila' Teaching Hospital of Nephrology, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania) ; Golan, Eliezer (Department of Nephrology and Hypertension, Meir Medical Center, Kfar-Saba and Sackler Faculty of Medicine, Tel Aviv, Israel) ; Heaf, James G. (Department of Medicine, Zealand University Hospital, Roskilde, Denmark) ; Hemmelder, Marc H. (Dutch Renal Registry (Renine), Nefrovisie, Utrecht, The Netherlands) ; Idrizi, Alma (Service of Nephrology, UHC 'Mother Teresa', Tirana, Albania) ; Ioannou, Kyriakos (Nephrology Department, Nicosia General Hospital, Nicosia, Cyprus) ; Jarraya, Faical (Research Unit 12ES14, Faculty of Medicine, Sfax University and Hedi Chaker University Hospital, Sfax, Tunisia) ; Kantaria, Nino (Department of Internal Medicine, Tbilisi State Medical University, Tbilisi, Georgia) ; Kolesnyk, Mykola (Main Coordinator of National Register of CKD and AKI Patients, State Institute of Nephrology, National Academy of Medical Sciences of Ukraine, Kiev, Ukraine) ; Kramar, Reinhard (Austrian Dialysis and Transplant Registry, Rohr, Austria) ; Lassalle, Mathilde (REIN Registry, Agence de la Biomédecine, Paris, France) ; Lezaic, Visnja V. (Department of Nephrology, Clinical Centre of Serbia, Belgrade, Serbia) ; Lopot, Frantisek (Department of Medicine, General University Hospital and 1st Charles University Medical School, Strahov, Czech Republic) ; Macario, Fernando (Nephrology Department, Portuguese Society of Nephrology, University Hospital of Coimbra, Coimbra, Portugal) ; Magaz, Ángela (Unidad de Información sobre Pacientes Renales de la Comunidad Autónoma del País Vasco (UNIPAR), Basque Country, Spain) ; Martín de Francisco, Angel L. (Servicio de Nefrología, Hospital Universitario Valdecilla, Santander, Cantabria, Spain) ; Martín Escobar, Eduardo (Registro Español de Enfermos Renales (REER), Organización Nacional de Trasplantes, Madrid, Spain) ; Martínez Castelao, Alberto (Member of the Catalan Renal Registry Committee, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain) ; Metcalfe, Wendy (Scottish Renal Registry, Meridian Court, ISD Scotland, Glasgow, UK) ; Moreno Alia, Inmaculada (Registro de Enfermos Renales en Tratamiento Sustitutivo de Castilla-La Mancha, Servicio de Epidemiología, Dirección General de Salud Pública y Consumo Castilla-La Mancha, Toledo, Spain) ; Nordio, Maurizio (Nephrology and Dialysis Unit, AULSS 15, Veneto, Italy) ; Ots-Rosenberg, Mai (Department of Internal Medicine, Faculty of Medicine, Institute of Clinical Medicine, Tartu University, Tartu, Estonia) ; Palsson, Runolfur (Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland) ; Ratkovic, Marina (Nephrology and Hemodialysis Department, Clinical Center of Montenegro, Ljubljanska, Montenegro) ; Resic, Halima (Head of Clinic for Hemodialysis, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina) ; Rutkowski, Boleslaw (Polish Renal Registry, Department of Nephrology, Transplantology and Internal Medicine, Medical University, Gdansk, Poland) ; Santiuste de Pablos, Carmen (Registro de Enfermos Renales de la Región de Murcia, Servicio de Epidemiología, Consejería de Sanidad, IMIB-Arrixaca, Murcia, Spain) ; Seyahi, Nurhan (Department of Internal Medicine, Cerrahpasa Medical Faculty, Division of Nephrology, Istanbul University, Istanbul, Turkey) ; Fernanda Slon Roblero, María (Consultant Nephrologist at Complejo Hospitalario de Navarra, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain) ; Spustova, Viera (Slovak Medical University, Bratislava, Slovakia) ; Stas, Koenraad J.F. (Dienst Nefrologie, Jessa Ziekenhuis, Campus Virga Jesse, Hasselt, Belgium) ; Stendahl, María E. (Swedish Renal Registry, Department of Medicine, Ryhov County Hospital, Jonkoping, Sweden) ; Stojceva-Taneva, Olivera (University Clinic of Nephrology, Medical Faculty of Skopje, Skopje, Macedonia) ; Vazelov, Evgueniy (Dialysis Clinic, 'Alexandrovska' University Hospital, Sofia Medical University, Sofia, Bulgaria) ; Ziginskiene, Edita (Nephrological Clinic, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania) ; Massy, Ziad (Institut National de la Santé et de la Recherche Médicale (INSERM) U1018, Team 5, CESP UVSQ, and University Paris Saclay, Villejuif, France) ; Jager, Kitty J. (ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; Stel, Vianda S. (ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands)
Background: This article summarizes the European Renal Association - European Dialysis and Transplant Association Registry's 2014 annual report. It describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2014 within 35 countries. [...]
2017 - 10.1093/ckj/sfw135
Clinical Kidney Journal, Vol. 10 (january 2017) , p. 154-169  
9.
9 p, 966.9 KB Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation / Domingo, Enric (Hospital Universitari Vall d'Hebron) ; Grignola, Juan C. (Universidad de la República, Montevideo, Uruguay) ; Aguilar, Rio (Hospital Universitario de la Princesa, Madrid) ; Messeguer, Manuel López (Hospital Universitari Vall d'Hebron) ; Roman, Antonio (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Pulmonary hypertension (PH) associated with lung disease has the worst prognosis of all types of PH. Pulmonary arterial vasculopathy is an early event in the natural history of chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). [...]
2017 - 10.1186/s12931-017-0568-z
Respiratory Research, Vol. 18 (may 2017)  
10.
9 p, 941.7 KB Isolated bilateral Tapia's syndrome after liver transplantation : A case report and review of the literature / Bilbao, Itxarone (Universitat Autònoma de Barcelona) ; Dopazo, Cristina (Universitat Autònoma de Barcelona) ; Caralt, Mireia (Universitat Autònoma de Barcelona) ; Castells, Lluis (Universitat Autònoma de Barcelona) ; Pando, Elisabeth (Universitat Autònoma de Barcelona) ; Gantxegi, Amaia (Universitat Autònoma de Barcelona) ; Charco, Ramón (Universitat Autònoma de Barcelona)
To describe one case of bilateral Tapia's syndrome in a liver transplanted patient and to review the literature. We report a case of bilateral Tapia's syndrome in a 50-year-old man with a history of human immunodeficiency virus and hepatitis C virus child. [...]
2016 - 10.4254/wjh.v8.i36.1637
World Journal of Hepatology, Vol. 8 (december 2016) , p. 1637-1644  

Artículos : Encontrados 18 registros   1 - 10siguiente  ir al registro:
Documentos de investigación Encontrados 8 registros  
1.
1 p, 1.7 MB Tolerogenic dendritic cells as a cell therapy to prevent chronic rejection in kidney transplantation / Molina Molina, Elisa ; Alvarez Perez, Iñaki, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Kidney transplantation (KT) is nowadays a routine procedure for people with end-stage renal disease. Treatment with immunosuppressive (IS) drugs has significantly decreased acute rejection rates. However, rates of long-term kidney loss have remained rather constant over the last decades due to the persistence of chronic allograft injury. [...]
2019
Grau en Ciències Biomèdiques [832]  
2.
25 p, 606.0 KB Actualización del tratamiento del carcinoma hepatocelular en el paciente con cirrosis hepática / Talens Orts, Paula ; Castells Fuste, Lluís, dir. ; Universitat Autònoma de Barcelona. Facultat de Medicina
El carcinoma hepatocelular (CHC) es la neoplasia primaria de hígado más frecuente y aparece mayoritariamente en pacientes con cirrosis hepática, siendo su principal causa de muerte. Su incidencia varía entre áreas geográficas en función de los diferentes factores etiológicos, como la infección por el virus de la hepatitis B, la infección crónica por el virus de la hepatitis C, el hábito enólico y la esteatosis hepática no alcohólica. [...]
Hepatocellular carcinoma (HCC) is the most frequent primary neoplasm of liver and appears mainly in patients with cirrhosis, being its main cause of death. Its incidence varies between geographic areas depending on the different etiological factors, such as hepatitis B virus infection, chronic hepatitis C virus infection, enolic habit and non-alcoholic hepatic steatosis. [...]

2017
Grau de Medicina [1192]  
3.
1 p, 352.1 KB Importance of vascularity in 3D bioprinting / Scotto, Fiorella ; Barrios, L. (Leonardo) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2016
Grau en Bioquímica [814]  
4.
1 p, 903.3 KB Faecal microbiota transplants and microbial ecosystem therapeutics as a treatment for recurrent Clostridium difficile infections / Antelo Granero, Rocío ; Luquín Fernández, M., (Marina) dir. (Universitat Autònoma de Barcelona. Departament de Genètica i Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Microbiologia [816]  
5.
1 p, 698.6 KB Fecal microbiota transplantation for recurrent Clostridium difficile infection / Casquero Galindo, Raquel ; Aranda Rodríguez, Jesús, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Microbiologia [816]  
6.
189 p, 3.0 MB Trasplante de progenitores hematopoyéticos en enfermedades genéticas con régimen de acondicionamiento de intensidad reducida en pacientes pediátricos / López Granados, Lucía ; Badell Serra, Isabel, dir. (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva) ; Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva
Introducción: El trasplante de progenitores hematopoyéticos (TPH) consiste en implantar elementos celulares capaces de generar un sistema hematopoyético nuevo y sano. El término régimen de acondicionamiento se refiere al tratamiento que se administra al paciente antes de la infusión de los progenitores hematopoyéticos. [...]
Introduction: Hematopoietic stem cell transplantation (HSCT) involves implanting cellular elements capable of generating a new and healthy hematopoietic system. The term conditioning regimen refers to treatment that the patient is administered prior to infusion of hematopoietic progenitors. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  
7.
139 p, 3.8 MB Evaluación de la función hepática en el trasplante alogénico de progenitores hematopoyéticos con acondicionamiento de toxicidad reducida / Barba Suñol, Pere ; Martino Bofarull, Rodrigo, dir. ; Sierra Gil, Jorge, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
La función hepática es vital para el correcto desarrollo del trasplante alogénico de progenitores hematopoyéticos (alo-TPH). Su alteración previa al trasplante puede condicionar de manera decisiva el tipo de acondicionamiento e incluso la misma indicación del procedimiento. [...]
En conclusión, las alteraciones de la función hepática juegan un papel determinante en los pacientes candidatos a un alo-TPH de toxicidad reducida por lo que es necesario un estricto control y manejo de las complicaciones. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  
8.
1 p, 11.3 MB Gene therapy for severe combined immunodeficiency disease / Medrano González, Laura ; Surrallés i Calonge, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2013
Grau en Genètica [833]  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.